ml10
Small moleculeexperimentalImaging agent
Clinical trial activity
3 trials · 2 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
1
Phase 3
0
Phase 4
0
Earliest trial started Nov 1, 2006 (NCT01254591)
Timeline
Indications
Studied for
Mechanism of action
- Unspecified targetRadiopharmaceutical
radiopharmaceutical
Chemistry & pharmacology
- Imaging
- 18-fluorine
Oral
No
Parenteral
No
Topical
No
Also known as
- 18f ml10
- 18f ml10
- 18f-ml-10
- 18f-ml-10
- ml10
- ml10
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT01476085 | Phase 1 | Jul 1, 2011 | GlaxoSmithKline |
| NCT01428440 | Phase 2 | Dec 1, 2009 | GlaxoSmithKline, University of London |
| NCT01254591 | N/A | Nov 1, 2006 | University of London |
Showing 3 of 3 trials
Page 1 / 1
Organizations
Research & Development (2)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| GlaxoSmithKline | For profit | 2 | 2 | 2 | 2009 |
| University of London | Academic/Hospital | 2 | 1 | 2 | 2006 |
2 organizations
Page 1 / 1